Stay updated with breaking news from Senza Omnia. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
StockNews.com began coverage on shares of Nevro (NYSE:NVRO – Free Report) in a report published on Thursday morning. The brokerage issued a hold rating on the medical equipment provider’s stock. Other equities analysts have also recently issued reports about the company. Oppenheimer dropped their target price on Nevro from $40.00 to $35.00 and set an […]
Nevro (NYSE:NVRO – Free Report) had its price objective reduced by Truist Financial from $27.00 to $25.00 in a research report report published on Thursday morning, Benzinga reports. Truist Financial currently has a hold rating on the medical equipment provider’s stock. Several other equities research analysts also recently weighed in on the company. Royal Bank […]
Nevro (NYSE:NVRO – Get Free Report) had its price objective decreased by research analysts at JMP Securities from $75.00 to $40.00 in a research report issued to clients and investors on Wednesday, Marketbeat.com reports. The firm currently has an “outperform” rating on the medical equipment provider’s stock. JMP Securities’ target price would suggest a potential […]
Nevro (NYSE:NVRO – Get Free Report) had its price objective lowered by equities researchers at Robert W. Baird from $26.00 to $23.00 in a report issued on Wednesday, MarketBeat.com reports. The firm presently has a “neutral” rating on the medical equipment provider’s stock. Robert W. Baird’s price target would indicate a potential upside of 11.87% […]
Nevro (NYSE:NVRO – Free Report) had its price target lowered by Wells Fargo & Company from $27.00 to $23.00 in a report released on Wednesday, Benzinga reports. The brokerage currently has an equal weight rating on the medical equipment provider’s stock. NVRO has been the subject of a number of other research reports. JMP Securities […]